Abstract--The aim of this paper is to investigate the conditions required to optimize the amount of chemotherapeutic drug absorbed by a solid tumour through a network of blood vessels. This work is based on a study of vascular networks generated from a discrete mathematical model of tumour angiogenesis [1] , which describes the formation of a capillary network in response to chemical stimuli released by a solid tumour. Simulations of blood flow in the vasculature connecting the parent vessel to the solid tumour are then performed by adapting modelling techniques from the field of petroleum engineering to this biomedical application [2] .
INTRODUCTION
Angiogenesis is the process by which new blood vessels develop from an existing vasculature, through endothelial cell sprouting, proliferation and fusion [3] . Adult endothelial cells are normally quiescent and, apart from certain developmental processes (e.g., embryogenesis), and wound healing, angiogenesis is generally a pathological process implicated in arthritis [4] , some eye diseases and tumour development, invasion and metastasis [5] . Tumour angiogenesis is believed to occur when a small avascular tumour exceeds some critical diameter (~2mm), above which normal tissue vasculature is no longer able to support its growth [6] . At this stage, the tumour cells lacking nutrients and oxygen become hypoxic. This is assumed to trigger cellular release of tumour angiogenic factors (TAFs) [7] , which start to diffuse into the surrounding tissue and approach the endothelial cells of nearby blood vessels. Endothelial cells subsequently respond to the TAF concentration gradient by forming sprouts, dividing and migrating towards the tumour [8] [9] [10] . It takes approximately 10 to 21 days for the growing network to link the tumour to the parent vessel [9, 11, 12] , and this vascular connection subsequently provides all the nutrients and oxygen required for continued tumour growth.
At this stage in turnout development, chemotherapy treatments can be administered and tumour cells can be specifically targeted via the newly developed vasculature. However, although most of the drugs used to date have proven to be successful on small animals (e.g., mice), their efficiency in humans remains highly variable from one patient to another. One of the main reasons suggested to explain such variability is the issue of drug delivery to the tumour--it is thought possible that most of the drug can bypass large areas of the target [13, 14] . Based on this fact, more theoretical models are being developed to try to better understand vascular architecture [15] [16] [17] and solve this issue [18] [19] [20] [21] .
McDougall et al. [2] were among the first to specifically model flow in a turnout-induced vascular network. This was achieved by adapting computational techniques that have been extensively developed in the context of the petroleum engineering industry to model flow through porous media. These methods were successfully applied in a biomedical setting, in particular to assess the efficiency of the drug delivery process to different types of vasculature. Indeed, vascular networks share some topological similarities with interconnected pore networks. This earlier study examined the relative importance of a variety of associated parameters either related to the vascular architecture itself (vessel radii) or to the blood properties (viscosity), which might influence the efficacy of the drug delivery process. It was thus possible to understand the circumstances under which bypassing effects might occur and to predict, for a given vasculature, the success of chemotherapy treatment.
In this paper, we extend the earlier work considerably in a number of important ways.
(i) 3D networks are generated and drug-uptake results compared with those from previous 2D simulations. We show that both the vascular connectivity and the system dimensionaiity affect drug delivery to the tumour.
(ii) A number of different vascular architectures are examined and the spatial distribution of the branching order and the anastomosis density (i.e., the number of fused connections) are quantified. These distributions are then used to infer treatment efficiency.
(iii) Capillary pruning of a flowing vasculature is studied, whereby certain capillary elements are removed either randomly or according to flow criteria. We then discuss how the results could help to define new cancer treatment therapies, such as a coupled treatment strategy that uses anti-angiogenic and chemotherapeutic agents sequentially.
A MATHEMATICAL MODEL FOR TUMOUR-INDUCED ANGIOGENESIS

A Discrete Stochastic Description of Network Growth
All of the vasculatures considered in this paper were generated on the basis of the tumourinduced angiogenesis model proposed by [1, 22] . This model describes how endothelial cells emerging from a parent vessel, respond and migrate through (i) random motility, (ii) chemotaxis via gradients of tumour angiogenic factor (TAF) released by the tumour, and (iii) haptotaxis via fibronectin gradients in the extracellular matrix.
We denote the endothelial cell density per unit area n, the TAF concentration c and the fibronectin concentration f. The nondimensional system of partial differential equations describing the vascular growth process is thus given by random chemotaxis haptotaxis
The chemotactic migration is characterized by the function X(c) = X/(1 + ac) which reflects the decrease in chemotactic sensitivity with increased TAF concentration. The coefficients D, X and p characterize the random, haptotactic and chemotactic cell migration, respectively, r 1 and 7 are coefficients describing the rates of TAF uptake and fibronectin degradation by the endothelial cells, respectively, and fl is the rate at which fibronectin is produced by migrating endothelial cells. In order to capture the salient features of network growth, such as branching and anastomosis (loop formation), we use the 3D discretized form of the system of partial differential equations (see [2] , for the 2D implementation). The discrete model allows us to track the motion of individual endothelial cells located at the capillary sprout tips and the subsequent formation of capillaries. The discretized 3D system of equations is obtained by using the standard Euler finite difference approximation [23] 
where l, m, w, and q are positive parameters which specify the location on the grid and the time step, i.e., x = IAx, y --mAy, z = wAz, and t = qAt. The migration of an individual endothelial cell located at the tip of a sprout is determined by the set of coefficients P0 to P6 which are proportional to the probabilities of the endothelial cell being stationary (Po), or moving left (P1), right (P2), up (P3), down (P4), out of the plane (P~), or into the plane (P6). These coefficients incorporate the effects of random, chemotactic and haptotactic movement and strongly depend upon the local chemical environment (fibronectin and TAF concentrations). The processes of branching (formation of new sprouts from existing sprout tips) and anastomosis (formation of loops by fusion of two colliding capillary sprouts) are incorporated into the discretized form of the model by assuming the following:
for branching -the probability for an existing sprout branching increases with the local TAF concentration, -a sprout must reach a certain level of maturation before it becomes capable of branching.
for anastomosis -if two sprouts collide as they grow, only one of them is allowed to keep growing (the choice of which is random), -if a sprout tip meets another sprout, they fuse to form a loop [24] .
Simulation Details of the Discrete Stochastic Model
Simulations are performed by calculating the coefficients P0 to P~ at each time step and these probabilities define the potential displacement directions for each endothelial cell located at each sprout tip. Probability ranges are then computed by summing the coefficients to produce five ranges
We assume that the endothelial cells cannot move back onto the sprouts from which they emerge. Therefore, each cell can either remain stationary or move in five possible directions (in 3D) (see Figure 1 for a 2D schematic). A random number between 0 and 1 is then generated. Depending on the range in which the number falls, the endothelial cell moves accordingly. The larger a particular range, the greater the probability that the corresponding coefficient will be selected. Figure 1 . Schematic diagram of a section of the 2D-grid used in the simulation procedure illustrating how the capillary sprout growth process is taken into account in the simulations. At each node~ the sprout can grow in three possible directions in 2D (and five possible directions in 3D). Each growing sprout is automatically assigned a radius in order to directly use the resulting network for flow simulations.
Network Growth Simulation
Figure 2 presents a 2D simulation for vascular network growth obtained using the model outlined above. This simulation was carried out on a 70 × 70 grid, with a space step Ax = Ay. In order to contain the growth within the limits of the domain, zero flux conditions were imposed on the boundaries of the grid. The initial distribution of fibronectin and TAF concentrations used in the simulation are the same as those discussed in [1] . For presentation purposes, we have arbitrarily chosen five positions, evenly distributed along the parent vessel, as our initial sprouting sites. taken as the diffusion coefficient for TAF [25, 26] . The simulation of vascular growth presented in Figure 2 shows the random character of each of the five sprout trajectories, which progress towards the tumour (the surface of which occupies the lower boundary of the domain). At time t = 2 (corresponding to t = 3 days), we observe that branching and anastomosis have already occurred. The local TAF concentration increases as the sprouts approach the tumour, the branching process is significantly amplified, and the sprout density and anastomosis density consequently increase. The resulting vasculature can now be directly used to perform flow simulations in order to investigate the efficiency of the network for drug delivery [2] .
M O D E L L I N G F L O W T H R O U G H A N E T W O R K
This area of research has been extensively studied in the context of petroleum engineering, where the main focus has been to investigate the flow of water, oil, and gas through the interstices of a porous rock (see, for example, [27] for an overview). Adaptation of fluid modelling techniques from the oil industry to biomedical applications has previously been performed by [2] .
Network flow calculations are based upon principles similar to those characterising Kirchoff's laws in electrical circuit theory--here, however, fluid mass and not electrical charge is the conserved variable. A lattice (2D) or network (3D) is constructed using interconnected capillary elements (of known geometry) and pertinent boundary conditions are imposed upon the system boundaries (usually, but not exclusively, these take the form of imposed pressure profiles). Before ensemble flows can be calculated, however, a local relationship between pressure gradient and flow must be assumed at the scale of a single capillary element. Poiseuille's law for flow in a rigid, impermeable, circular cylinder has been assumed here, where the flow rate is given by
where # is the fluid viscosity, A P is the pressure drop across the vessel, R and L are the radius and length of the vessel, respectively. Clearly, this assumption is somewhat idealistic at the capillary scale and it is rather radical to assume that blood can be modelled as a continuum of constant viscosity. In reality, capillary beds are characterized by unsteady-state flow dynamics, with some capillaries periodically stagnant. However, more complex flow/pressure-drop relationships (including haematocrit-dependent viscosity, and R(P) relationships) can easily be incorporated into the formulation at a later date. For now, we restrict ourselves to Poiseuille-type flow and will take the term 'Mscosity" as a cipher for "apparent viscosity" (see [28] , for a fuller treatment). Assuming mass conservation and incompressible flow at each junction where capillary elements meet (a node), we can write for each node
k=l where the index k refers to adjacent nodes and N = 4 in 2D and 6 in 3D. This procedure leads to a set of linear equations for the nodal pressures (Pi) which can be solved numerically using any of a number of different algorithms (e.g., Successive Over-Relaxation (SOR), Choleski conjugate gradient method, Lanczos method). Once nodal pressures are known, equation (3) can be used to calculate the flow in each capillary element in turn. When simulating drug infusions, these elemental flows are used to update capillary drug concentrations at each time step (with complete mixing assumed at each node). A fuller account of this procedure can be found in [2] .
Q U A L I T A T I V
In this section, we compare drug delivery in 2D and 3D vasculatures--the two vasculatures considered in these simulations are displayed in Figure 3 , where the 2D vasculature corresponds to the network whose growth was presented earlier in Figure 2 . The dimensions of the grid for the 2D network were 70 × 70 and the 3D vasculature was "grown" (i.e., simulated) on a 30 × 30 × 30 domain. In both cases, a continuous infusion treatment regime was simulated by fixing the input drug concentration to Cmax at the inlet of the parent vessel (left-hand side in all figures). The time was normalizing using the "filling time" of the parent vessel (volume/flow) as follows The values of the parent vessel variables are given in Table 1 . These are in line with experimental data and physiological observations (see [29] ). Simulations were continued until the mass of drug in each vaseulature tended towards a steady state (corresponding to t* = 1000 in 2D and 5000 in 3D, Pigure 4) . Figure 5 shows the drug evolution for the 2D case, whilst the 3D concentrations are given in Figure 6 . At a normalized time of t* = 150, it can be seen from the 2D simulations that some drug has reached the tumour although some bypassing and return flow to the parent vessel has already begun (via the 4 th branch along the parent vessel). In the aD case, we observe that drug reaches the tumour at a similar time and the bypassing of the drug is also occurring.
A, STEPHANOU ¢t al. At this stage, our aim is not to provide a detailed quantitative comparison of drug delivery efficiency for 2D and 3D networks but rather to evaluate, on a qualitative basis, the influence of various parameters (e.g., blood viscosity and vessel radii) upon drug uptake by the tumour. The aim here is to extend the 2D results published in a previous paper by [2] to 3D networks. Figure 7 presents, in parallel, the results obtained for the 2D and 3D vasculatures up to steady-state (left and right columns, respectively). In both eases, three series of simulations have been performed.
The first series (Figures 7a and 7b) examines the influence of blood viscosity (/z --1, # --4, and # --8cp), the second (Figures 7c and 7d ) the influence of mean capillary radius ((r) --2, (r) = 4, and (r) = 6 #m), and the third (Figures 7e and 7f) the influence of the regime of delivery (continuous or bolus injection of the drug). We observe that, the sensitivities are similar in both 2D and 3D--an increase in blood viscosity and/or a decrease in mean capillary radius contribute to an increase in circulatory resistance and this considerably slows down the delivery of the drug to the tumour. Figure 8 highlights a direct comparison of drug delivery to the tumour between 2D and 3D vasculatures (left and right columns show sensitivity to blood viscosity and mean capillary radius, respectively). When observed over a timescale t* < 1000, we see that delivery via the 3D network is initially far slower: the three-dimensional vasculature has very different percolation properties associated with it [30] and any treatment must negotiate highly tortuous pathways before reaching the tumour. These results clearly demonstrate that it is the combined effects of branching/anastomosis density, dimensionality of the vasculature, and duration of the infusion itself that ultimately determine how much drug reaches the target site. The comparisons above are somewhat qualitative in nature. In order to make more meaningful quantitative comparisons between the 2D and 3D simulation results, we normalize drug delivery data using the "capacity" of each vasculature. The capacity of the vasculature is defined as the maximum mass of drug that the vasculature can potentially contain (i.e., if it was completely filled with drug at maximum concentration). Table 2 shows a number of normalized measures for 2D simulations (t* < I000) and Table 3 the corresponding results for 3D simulations (t* _~ 5000). In all cases, simulations continued until the mass of drug in each vasculature tended towards a steady state.
In both 2D and 3D networks, it is clear that the steady-state concentration distribution does not correspond to a network that is fully saturated with drug. In 2D, the capillary bed only reaches between 65.4% and 80.9% saturation, whilst the 3D system only attains 57-63.2%. This is due to the numerous "dead-end" and re-circulating capillaries that contribute little to the flowing backbone of the vasculature. Extraneous recirculation can be more dominant in the 3D case. Perhaps the most striking results relate to the percentage of injected drug that has actually reached the tumour at steady state. In both 2D and 3D simulations, a staggering 97 and 99.9% of the injected treatment bypassed the tumour completely. These results clearly show that some measure of vessel connectivity and anastomosis density should be taken into account when planning chemotherapy treatment regimes. These issues will be examined more fully in the next section.
NETWORK CONNECTIVITY AND EFFICIENCY OF DRUG DELIVERY TO THE TUMOUR
Comparison of Drug Delivery Via Three Different Vasculatures
The vascular networks generated from our model agree with the observation that there exists a wide range of heterogeneity in tumour-induced capillary architecture. This depends upon many This procedure allows us to construct a two-part "fingerprint" for each of the different network configurations. z=4 z=3 z=2 Z=I F i g u r e 10. R e p r e s e n t a t i o n of t h e 4 p o s s i b l e c o n n e c t i o n s e n c o u n t e r e d a t a j u n c t i o n ( n o d e ) of a 2 D v a s c u l a r g r i d .
--
Part (i) a unique branching map can be constructed by using different colours to show the spatial distribution of each branching coefficient z~ (Figure 9a , 9c, and 9e), and _tot (defined above) and plotted
Part (ii) a graphical signature can be constructed from the ~i (Figure 9b, 9d, and 9f) .
The three networks that we choose to consider are characterized by significantly different signatures. The first network (Figure 9a and 9b ) exhibits a gradual increase in anastomosis density as the vessels approach the tumour. The connectivity of the network is dominated by z2 near the parent vessel but evolves towards a more homogeneous representation of the connections z4, z3, and z2 in the distal part of the vasculature (i.e., near the tumour). The second network (Figure 9c and 9d) was generated by considering a decrease in the haptotactic coefficient. The vascular growth is then dominated by chemotactic effects, which reduce the lateral migration of the endothelial cells. This leads to longer main vessels which start to branch only when they become very close to the tumour surface. The signature of the network reflects the observed differences. The final network was obtained by considering a small circular tumour (located in the middle of the right-hand boundary) as the source of tumour angiogenesis factor (TAF), leading to a radially s y m m e t r i c initial T A F c o n c e n t r a t i o n profile. In this particular case, the network is characterized by a low density of poorly connected vessels and the contribution of nodes with connectivity z4 is negligible.
Simulations of blood flow in each vasculature were performed and, in each case, identical bolus injections were input to the parent vessel. The results are shown in Figure 11 . Figure l l a shows how the total mass of drug in the vasculature varies with time--observe the sharp decrease in drug concentration at time t* = 150, corresponding to the end of the bolus injection and subsequent post-flush with clean blood. Despite the same amount of drug being injected into each of the three corresponding parent vessels, we observe that the total amount of drug remaining at the end of the injection period varies from case to case. This is due to the fact that in some vasculatures, notably 2 and 3, some drug leaves the network while the parent vessel is still delivering the treatment. Figure l l b shows the corresponding plots of drug uptake by the tumour. We see that, at time t* = 150, only vasculature 2 has delivered drug to the tumour. No uptake has yet occurred via vasculature 1, although most of the drug injected is still dispersed in the network. For vasculature 3, the drug has bypassed the tumour completely and has simply recirculated to the parent vessel.
Visualization of the distribution of capillary blood flow in each of the three vasculatures (Figure 12) is extremely useful in interpreting these results. In network 3 (Figure 12c ), for example, flow is high only in the two main vessels, which form a loop causing the drug to bypass the entire system. The rest of the network is dominated by poorly perfused capillaries. In vasculatures 1 and 2 (Figures 12a and 12b) , flow is sufficiently high in the distal region of the capillary bed (close to the tumour) to expedite drug delivery. The average capillary flow in vasculature 2 is significantly higher than that in vasculature 1 due to its lower anastomosis density and this explains why vasculature 2 delivers drug far more efficiently. Fraction Removed (FR) Figure 13 . Plot of the total amount of drug received by the tumour at t* = 1000 vs. fraction of vessels randomly removed from the capillary bed (the fraction removed, FR, is varied from 0.0 to 0.18.
Influence of a posteriori Changes in Network Connectivity and A n a s t o m o s i s Density U p o n Drug Uptake
In this section, we investigate more closely the delivery characteristics of vasculature 1. The aim is to determine how modifications to the network connectivity might influence the efficiency of drug delivery to the turnout. The motivation for this comes from the possibility of target- ing particular areas of a growing vasculature with cytotoxic compounds (e.g., anti-angiogenesis drugs). The current study focuses upon a posteriori capillary pruning (i.e., capillary removal from a static pre-existing capillary bed). However, this should be envisaged as a first step towards dynamic vascular remodelling, where capillary architecture is modified as the bed itself is still growing and forming. At present, modifications are achieved by removing a fraction of vessels in the distal part of the vasculature (from ordinates y = 40 to y --70).
Three pruning algorithms have been considered:
(i) vessels are removed in a totally random fashion; (ii) vessels are removed if their flow lies below a given threshold; (iii) vessels are removed if their flow exceeds a given threshold.
These three approaches seek to cover the spectrum of possible targeting strategies for antiangiogenic treatments--the first relates to a broad-based indiscriminate anti-vascular drug, the second relates to an anti-angiogenic drug that preferentially targets immature, poorly perfused capillaries, and the third relates to the possible targeting of capillaries characterized by high wall stresses. In all simulations, a bolus injection at concentration Cmax and duration t* --150 was considered. corresponds to the time at which drug uptake via the unpruned vasculature (i.e., FR = 0.0) ceased (see Figure 11) . We observe from Figure 13 that, the total amount of drug uptake increases to a maximum for FR = 0.06. A sharp decrease is then observed, corresponding to poorly connected architectures that are unable deliver drug effectively.
R a n d o m vessel removal
Visualization of the flow distribution in the optimized vasculature is given in Figure 14 , together with the corresponding branching/anastomosis signature of the network. We observe an increase in flow in the distal part of the capillary bed (close to the tumour) due to a decrease in the z4 branching coefficient and increases in z3 and z2. This redistribution increases the efficacy of drug delivery to the turnout by 130% (Figure 14d) . These simulations clearly show that drug delivery to a turnout becomes optimized when (i) highly interconnected regions of the vasculature are removed (i.e., z4 is decreased); and (ii) a high capillary density can be preserved close to the tumour surface.
If an anti-vascular treatment could achieve this architecture, then the efficacy of subsequent chemotherapy treatments would be much improved. However, we should also point out that if an anti-vascular agent were to be used in isolation (i.e., without chemotherapeutic follow-up), then the effect may be to simply optimize nutrient supply and this could actually encourage tumour growth.
Flow-dependent vessel removal: low flow rate threshold
As we saw in previous simulations, the process of random removal of vessels can lead to drastic changes in drug delivery to a tumour and these variations can be either positive or negative. In this section, motivated by the possibility of targeting drugs at poorly perfused areas of the vasculature, we selectively remove some of the vessels whose flow falls below a given threshold value. Figure 15 shows a case where vessels having flow less than 1% of the maximum capillary flow (Qmax) were removed (the vessels removed are highlighted in Figure 15c )--the fraction removed represents 40% of the total capillary bed. We observe that the flow distribution remains essentially unchanged when compared with the unmodified vasculature and a comparison of drug uptake in the two systems shows that maximum uptakes are also similar. We note, however, that the modified network initially delivers the drug more quickly: the "treated" vasculature has been optimized and drug delivery is accelerated by approximately 30%.
Flow-dependent vessel removal: High flow rate threshold
The final approach to capillary pruning relates to the possible targeting of "bottleneck" capillaries characterized by high wall stresses. In this scenario, capillaries with flow within 5% of the maximum network flow were removed--this correspond to a removed fraction FR --0.05. Figure 16 shows the resulting flow distribution, branching/anastomosis signature, and uptake profile. We observe that the network has essentially shut down in this case, with no drug delivery to the tumour. Hence, if an anti-angiogenic treatment could be developed to target these fast-flowing "bottleneck" capillaries, it would be a highly efficient way of slowing tumour growth.
The results presented in this section have shown that drug delivery to a tumour is highly sensitive to the associated capillary architecture. Moreover, we have also shown that the main flowing backbone plays a dual role: it helps to carry the blood towards the tumour but also contributes to a lot of bypassing. It is the management of this flowing backbone that antiangiogenic therapies should address.
DISCUSSION AND CONCLUSION
The main aim of this paper has been to examine the issue of capillary blood flow in tumourinduced vasculatures. In particular, we have identified the conditions under which drug delivery to a tumour is optimized. 3D networks have been generated and drug-uptake results compared with those from previous 2D simulations. We have shown that both vascular connectivity and system dimensionality affect delivery to the tumour--in particular, extraneous recirculation seems to be a dominant effect in 3D networks. In both 2D and 3D simulations, 97 to 99.9% of the injected treatment drug bypassed the tumour completely and these results clearly show that some measure of vessel connectivity and anastomosis density should be taken into account when planning treatment regimes.
The second part of the paper has focussed upon a number of different vascular architectures and the spatial distribution of branching order and anastomosis density have been quantified. These distributions have subsequently been used to infer treatment efficiency. We have shown that the most favourable conditions for drug uptake are those where the density of capillaries is high in the distal region of the vasculature (near the tumour surface), together with a small number of anastomoses in the region proximal to the parent vessel. The combination of these two conditions significantly reduces bypassing effects.
Having compared different capillary networks characterized by different connectivity/anastomosis signatures, we then focussed on one particular vasculature and investigated how vessel removal (capillary pruning) affected the distribution of blood flow in the system. Capillary pruning was done either randomly or according to flow criteria. Random removal of vessels showed that is was possible to significantly increase uptake (by around 130%). This was due to slight modifications in the backbone structure of the vasculature, which allowed redirection of the flow preferentially towards the tumour. Random removal also preserved a high capillary density near the tumour surface. In the case of low-flow capillary pruning, 40% of the vessels with the lowest flow magnitude (< 1% of the maximum flow) were removed. Whilst drug uptake was not improved (as the backbone structure remained essentially unmodified), the speed of delivery was accelerated by 30% due to the removal of extraneous dead-end vessels. In the case of high-flow capillary pruning, where vessels with flow within 5% of the maximum flow were removed, the main vessels feeding the tumour became ineffective and delivery to the tumour was completely shut down. If an anti-vascular treatment could be developed to target these fast-flowing "bottleneck" capillaries, it would be a highly efficient way of slowing tumour growth.
Experimentally, alteration of the vasculature is made possible by the use of anti-vascular factors [31] [32] [33] . These factors are mainly used at an early stage of tumour development in order to prevent the formation of the vasculature, which otherwise will feed the tumour and allow it to grow and spread (via dissemination of tumour cells). However, at a later stage of tumour development, i.e., when the tumour is already vascularized, antiangiogenic factors can still be used to disturb the constant reorganization of the capillary bed [34] . Antiangiogenic factors are usually efficient in destroying younger immature vessels, i.e., those that have not yet stabilized their structure with periendothelial cell coating [35, 36] and these vessels mainly correspond to small capillaries characterized by low-flow magnitudes. This would justify our choice of removing low-flow vessels in some of our simulations.
The fact that the drug uptake can be increased by the random removal of vessels suggests the possibility of coupling an anti-vascular treatment (to preliminarily optimize the vasculature) with chemotherapy treatment to ensure maximum uptake. One possible way to test the efficiency of the antiangiogenesis treatment and its effect on flow distribution could be to monitor the intensity of a fluorescent probe injected before and after the treatment.
Whilst the work presented here has dealt with individual vascular beds emerging from a single parent vessel, we should note that, in vivo, the tumour may be fed by a number of different vascular networks emerging from different parent vessels (Figure 17 ). Subtle differences in architecture mean that each of these vasculatures could respond differently to an antiangiogenesis treatment--some may become totally inefficient for drug delivery whilst others could become optimized. This would result in a highly heterogeneous distribution of drug to the tumour, with some regions being killed by high concentrations of cytotoxic drugs and other regions becoming hypoxic and triggering the release of additional angiogenic factors. Several cycles of coupled antiangiogenic and chemotherapy treatments should then be considered as a potential solution to contain tumour growth. 
